Work

Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database

Year: 2022

Type: article

Study design: Observational Study

Source: Leukemia Research

DOI: 10.1016/j.leukres.2022.106903

Authors: Noa Rippel, Douglas Tremblay, Nicole Zubizarreta, Nikolai Podoltsev, Jason Gotlib, Mark Heaney, Andrew Kuykendall, Casey O’Connell, Jamile M. Shammo, Angela Fleischman, Marina Kremyanskaya, Ronald Hoffman, Ruben Mesa, Abdulraheem Yacoub, John Mascarenhas

Institutions: Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Yale University, Stanford Cancer Institute, Stanford University, Columbia University Irving Medical Center, Moffitt Cancer Center, University of Southern California, Rush University Medical Center, University of California, Irvine, The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, The University of Kansas Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Mays Cancer Center at UT Health SA, Cancer Center Support Grant, The Tisch Cancer Institute - Cancer Center Support Grant

OpenAlex ID: W4282969329

FWCI: 0.155

Cites: 33

Cited by: 1

Related to: 10